NASDAQ · IRWD
Ironwood Pharmaceuticals, Inc.
$3.62+$0.01 (+0.28%)
Ironwood Pharmaceuticals, Inc.’s quoted price sits in the lower half of its reported 52-week range, 37.37% below the high.
Loading market information…
NASDAQ · ACB · USD
Stock price, earnings
Quote as of Oct 29, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Aurora Cannabis Inc.’s quoted price sits in the lower half of its reported 52-week range, 35.85% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Aurora Cannabis Inc.’s next earnings report is currently expected on Nov 11, 2026, with estimated earnings per share of -$0.03. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Aurora Cannabis Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Aurora Cannabis Inc. is a leading company in the global cannabis industry, focusing on the cultivation, production, and sale of various cannabis and cannabis-derived products across Canada and internationally. Beyond its core product offerings, the company engages in a broad spectrum of related activities, including the design and engineering of facilities, cannabis breeding programs, research and development, and both wholesale and retail distribution channels. For medical users, Aurora provides a diverse selection of products such as different strains of dried cannabis, cannabis oils, capsules, and topical kits. Their inventory also includes ancillary items like vaporizers, vaporizer accessories, herb mills (specifically for CanniMed products), grinders, and secure containers for vaporizers. The company is actively involved in developing advanced medical cannabis products, with ongoing work on oral, topical, edible, and inhalable formulations. Furthermore, Aurora manages CanvasRX, a network of centers dedicated to cannabis counseling and community outreach. Its service portfolio extends to providing patient support, specialized design and construction services, and comprehensive analytical testing for cannabis products. Aurora Cannabis Inc. manages an extensive collection of brands, including Aurora, Aurora Drift, San Rafael '71, Daily Special, AltaVie, MedReleaf, CanniMed, Whistler, Woodstock, and WMMC. The company's main corporate office is located in Edmonton, Canada.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 03:09 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
| Q4 2025 | Jun 18, 2025 | -$0.24-321.08% vs estimate | $62.91M+1.93% vs estimate |
|---|
| Q3 2025 | Feb 5, 2025 | $0.40+11,688.69% vs estimate | $61.29M+10.43% vs estimate |
|---|
| Q2 2025 | Nov 6, 2024 | $0.04+118.18% vs estimate | $59.95M+16.29% vs estimate |
|---|
THE ANALYST VIEW
14 ratings in the current snapshot. Strong buy and strong sell are grouped with buy and sell.
Percentages compare targets with the quoted price when currencies match. Targets are analyst estimates, not guaranteed outcomes.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$3.62+$0.01 (+0.28%)
Ironwood Pharmaceuticals, Inc.’s quoted price sits in the lower half of its reported 52-week range, 37.37% below the high.
$3.99+$0.03 (+0.76%)
Aclaris Therapeutics, Inc.’s quoted price sits in the lower half of its reported 52-week range, 39.55% below the high.
$2.93-$0.02 (-0.68%)
Editas Medicine, Inc.’s quoted price sits in the upper half of its reported 52-week range, 25.63% below the high.
$8.09+$0.23 (+2.93%)
Alpha Teknova, Inc.’s quoted price sits in the upper half of its reported 52-week range, 14.66% below the high.
$0.68+$0.00 (+0.46%)
Canopy Growth Corporation’s quoted price sits in the lower half of its reported 52-week range, 71.64% below the high.
$6.52+$0.01 (+0.15%)
Lifecore Biomedical, Inc.’s quoted price sits in the upper half of its reported 52-week range, 27.39% below the high.
$2.66-$0.03 (-1.12%)
High Tide Inc.’s quoted price sits in the upper half of its reported 52-week range, 15.02% below the high.
$5.94$0.00 (0.0%)
BioAge Labs Inc.’s quoted price sits in the lower half of its reported 52-week range, 77.12% below the high.
